2024-514446-36-00招募中1 期
A Study of ZL-1310 in Patients with Small Cell Lung Cancer to Find a Suitable Dose and to Test How Different Doses of ZL-1310 are Tolerated by the Body and How the Body Absorbs, Distributes, Metabolizes and Excretes ZL-1310
Zai Lab (Shanghai) Co. Ltd.11 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年10月31日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
- 试验地点
- 11
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Yinjia Fu
Scientific
Zai Lab (Shanghai) Co. Ltd.
研究点 (11)
Loading locations...
相似试验
招募中
1 期
A Study of ZL-1218 with or without Pembrolizumab in Subjects with Advanced Solid Tumor Cancers to Find a Suitable Dose and to Test How Different Doses of these Medications can be Tolerated by the Body2022-503102-20-00Zai Lab (Shanghai) Co. Ltd.40
已完成
2 期
A phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors2022-502367-37-00Novartis Pharma AG55
招募中
1 期
A Study of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment2025-521947-19-00Eli Lilly & Co.26
招募中
2 期
A Clinical study of MK-4716 in people with certain solid tumors (MK-4716-001)2025-522495-84-00Merck Sharp & Dohme LLC29
招募中
1 期
A trial to learn if AZD9829 is safe and works alone and in combination with other treatments for participants with certain blood cancers.2023-506997-11-00Astrazeneca AB14